RCM
RA Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,755,577
| Closed | -$45.6M | – | 69 |
|
|
2025
Q1 | $45.6M | Hold |
5,755,577
| – | – | 0.76% | 25 |
|
|
2024
Q4 | $72.9M | Sell |
5,755,577
-2,116,144
| -27% | -$26.8M | 0.97% | 24 |
|
|
2024
Q3 | $110M | Hold |
7,871,721
| – | – | 1.26% | 23 |
|
|
2024
Q2 | $108M | Buy |
7,871,721
+61,869
| +0.8% | +$853K | 1.43% | 20 |
|
|
2024
Q1 | $129M | Hold |
7,809,852
| – | – | 1.64% | 19 |
|
|
2023
Q4 | $114M | Hold |
7,809,852
| – | – | 1.78% | 13 |
|
|
2023
Q3 | $95.8M | Hold |
7,809,852
| – | – | 1.89% | 14 |
|
|
2023
Q2 | $93.2M | Buy |
7,809,852
+769,230
| +11% | +$9.18M | 1.76% | 17 |
|
|
2023
Q1 | $94.1M | Hold |
7,040,622
| – | – | 2.13% | 16 |
|
|
2022
Q4 | $152M | Hold |
7,040,622
| – | – | 3.07% | 7 |
|
|
2022
Q3 | $141M | Hold |
7,040,622
| – | – | 3.01% | 5 |
|
|
2022
Q2 | $126M | Buy |
7,040,622
+980,532
| +16% | +$17.6M | 3.36% | 5 |
|
|
2022
Q1 | $60.1M | Buy |
6,060,090
+1,094,502
| +22% | +$10.9M | 1.31% | 22 |
|
|
2021
Q4 | $83.7M | Hold |
4,965,588
| – | – | 1.48% | 18 |
|
|
2021
Q3 | $118M | Hold |
4,965,588
| – | – | 1.63% | 21 |
|
|
2021
Q2 | $113M | Buy |
+4,965,588
| New | +$113M | 1.81% | 14 |
|